CytoDyn Inc. CYDY
OTC PK
| 08/31/2026 | 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -57.10M | -42.70M | -38.79M | -38.86M | -21.02M |
| Total Depreciation and Amortization | 32.00K | 17.00K | 17.00K | 18.00K | 17.00K |
| Total Amortization of Deferred Charges | -- | -- | 59.00K | 169.00K | 282.00K |
| Total Other Non-Cash Items | 20.10M | 3.56M | 3.33M | 1.27M | 1.25M |
| Change in Net Operating Assets | 14.44M | 21.87M | 17.40M | 19.98M | 2.82M |
| Cash from Operations | -22.53M | -17.25M | -17.98M | -17.42M | -16.66M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | -142.00K | -142.00K | -142.00K | -142.00K |
| Issuance of Common Stock | 28.68M | 16.47M | 16.51M | 1.21M | 1.21M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 874.00K | 874.00K | 874.00K | 0.00 | 0.00 |
| Cash from Financing | 29.56M | 17.20M | 17.24M | 1.07M | 1.07M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.03M | -51.00K | -745.00K | -16.35M | -15.59M |